APA (7th ed.) Citation

Liu, S., Ke, J., Feng, X., Wang, Z., Wang, X., Yang, L., & Zhao, D. (2024). The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus. Journal of Diabetes Research, 2024, 1. https://doi.org/10.1155/2024/2431441

Chicago Style (17th ed.) Citation

Liu, Simo, Jing Ke, Xiaotong Feng, Zongwei Wang, Xin Wang, Longyan Yang, and Dong Zhao. "The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus." Journal of Diabetes Research 2024 (2024): 1. https://doi.org/10.1155/2024/2431441.

MLA (9th ed.) Citation

Liu, Simo, et al. "The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus." Journal of Diabetes Research, vol. 2024, 2024, p. 1, https://doi.org/10.1155/2024/2431441.